Skip to content Skip to footer
Subscribe Now
TOP 20

Top 20 Vaccines of 2026

Shots:   The global vaccine market, valued at $72.8B in 2025 and projected to reach $115.8B by 2033, continues to benefit from expanding immunization coverage, growing awareness of infectious disease prevention, and innovation across RSV, pneumococcal, HPV, and mRNA vaccines. Pfizer’s Prevnar Family led the market with $6.49B in revenue, followed by Merck’s Gardasil/Gardasil 9 ($5.23B)…
June 26, 2026

Read more

Vaccines Top 20 2024
TOP 20

Top 20 Vaccines of 2024

Shots: Vaccines play an instrumental role in curbing infectious diseases by generating antibodies against antigens and creating a memory to defeat them. Several biopharma companies are steadfastly working to deliver vaccines against infectious and vaccine-preventable diseases around the world In 2024, the global vaccine market is estimated to be around $78B and is expected to…
July 11, 2024

Read more

Vaccines Based Top 20 2022
TOP 20

Top 20 Vaccines Based on 2022 Total Revenue

Shots: Driven by a noble pursuit to ensure global health security, vaccines cater to the healthcare needs of millions and billions of people. With an instrumental role in containing the COVID-19 pandemic, immunization prevents more than 5 million deaths annually from conditions like diphtheria, tetanus, pertussis, influenza, and measles With a global market size of…
July 25, 2023

Read more